Revolution Medicines, Inc. · NASDAQ:RVMD
Goldsmith Mark A sold 120,000 Revolution Medicines, Inc. shares (Form 4)
Traded Apr 15, 2026 · Filed Apr 17, 2026
On Apr 15, 2026, Goldsmith Mark A (Director, See Remarks) sold 120,000 Revolution Medicines, Inc. shares at US$150.09 for US$18M under a trading plan, leaving 276,698 shares. Filed Apr 17, 2026 (Form 4).
- Sold
- 120,000 shares
- Price
- US$150.09
- Value
- US$18M
- Holding after
- 276,698 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 15, 2026 | Common Stock | Option exercise | 23,244 | US$4.09 | 299,942 | Direct |
| Apr 15, 2026 | Common Stock | Option exercise | 96,756 | US$4.73 | 396,698 | Direct |
| Apr 15, 2026 | Common Stock | Sale | 120,000 | US$150.09 | 276,698 | Direct |
Source
Related
- Revolution Medicines, Inc.
- Goldsmith Mark A
- Revolution Medicines, Inc. shareholders
- Form 4 · Goldsmith Mark A · Sep 18, 2026
- Form 4 · Goldsmith Mark A · Aug 25, 2026
- Form 4 · Goldsmith Mark A · Jun 18, 2026
- Form 4 · Sandler Alan B. · Oct 1, 2026
- Form 4 · Cislini Jeff · Sep 29, 2026
- Form 4 · Mancini Anthony · Sep 28, 2026
- Form 4 · Anderson Elizabeth M · Sep 24, 2026
- Form 4 · Mancini Anthony · Sep 22, 2026